B J Boucher. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amiodarone/administration & dosageContraindicationsDipeptidyl-Peptidase IV InhibitorsDrug Therapy, CombinationHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHypolipidemic AgentsLiver-Specific Organic Anion Transporter 1MaleOrganic Anion TransportersPyrazinesRenal Insufficiency/complicationsRenal Insufficiency/drug therapyRhabdomyolysis/chemically inducedRhabdomyolysis/geneticsSimvastatin/administration & dosageSitagliptin PhosphateTriazolesUnited KingdomUnited States
Substances: See more » Dipeptidyl-Peptidase IV InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsLiver-Specific Organic Anion Transporter 1Organic Anion TransportersPyrazinesSLCO1B1 protein, humanTriazolesSimvastatinAmiodaroneSitagliptin Phosphate
Year: 2009 PMID: 19236630 DOI: 10.1111/j.1464-5491.2008.02659.x
Source DB: PubMed Journal: Diabet Med ISSN: 0742-3071 Impact factor: 4.359